CoChat

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease

Open access

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

In mammalians, toll-like receptors (TLR) signal-transduction pathways induce the expression of a variety of immune-response genes, including inflammatory cytokines. It is therefore plausible to assume that TLRs are mediators in glial cells triggering the release of cytokines that ultimately kill DA neurons in the substantia nigra in Parkinson disease (PD). Accordingly, recent data indicate that TLR4 is up-regulated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment in a mouse model of PD. Here, we wished to evaluate the role of TLR4 in the acute mouse MPTP model of PD: TLR4-deficient mice and wild-type littermates control mice were used for the acute administration way of MPTP or a corresponding volume of saline. We demonstrate that TLR4-deficient mice are less vulnerable to MPTP intoxication than wild-type mice and display a decreased number of Iba1+ and MHC II+ activated microglial cells after MPTP application, suggesting that the TLR4 pathway is involved in experimental PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep01393

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A): HPLC measurement of striatal dopamine (DA) and homovanillic acid (HVA) levels, as well as calculation of the HVA/DA-ratio after MPTP-intoxication of TLR4- deficient (TLR def) and WT mice in comparison to saline treated mice.Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP treated group with its saline control, #p < 0.05 comparing MPTP-treated groups of WT and TLR4-deficient mice. (B): TH-positive cell number in SN after MPTP treatment. WT = WT mice, TLR deficient = TLR4 deficient mice. Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP treated group with its saline control). (C): Representative photographs of the SN of each treatment group is shown. TH-staining of free-floating cryomicrotome-cut sections at day 7. TLR4-deficient = TLR4-deficient mice, WT = wild-type mice. Control = saline treated mice, MPTP = MPTP-treated mice, Scale bars = 200 μm.
Figure 1 (A): HPLC measurement of striatal dopamine (DA) and homovanillic acid (HVA) levels, as well as calculation of the HVA/DA-ratio after MPTP-intoxication of TLR4- deficient (TLR def) and WT mice in comparison to saline treated mice.Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP treated group with its saline control, #p < 0.05 comparing MPTP-treated groups of WT and TLR4-deficient mice. (B): TH-positive cell number in SN after MPTP treatment. WT = WT mice, TLR deficient = TLR4 deficient mice. Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP treated group with its saline control). (C): Representative photographs of the SN of each treatment group is shown. TH-staining of free-floating cryomicrotome-cut sections at day 7. TLR4-deficient = TLR4-deficient mice, WT = wild-type mice. Control = saline treated mice, MPTP = MPTP-treated mice, Scale bars = 200 μm.CC BY-NC-ND · PubMed Central
Figure 2 (A): Number of nigral Iba+ microglia at day 2 and day7.WT = WT mice, TLR def = TLR4-deficient mice. Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP-treated group with its saline control, #p < 0.05 comparing MPTP-treated groups of WT and TLR4-deficient mice). (B): MHC II+ cell number in SN after MPTP treatment at day 2. WT = WT mice, TLR def = TLR4-deficient mice. Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP-treated group with its saline control, #p < 0.05 comparing MPTP-treated groups of WT and TLR4-deficient mice). (C): Representative photographs of the SN (Iba-1 staining) of each treatment group at day 2 are shown. TLR4 def = TLR4-deficient mice, WT = wild-type mice. Control = saline treated mice, MPTP = MPTP treated mice. Scale bars = 200 μm. (D): Correlation analysis of TH+- and Iba+-positive cells counts at day 7 in SNpc (r = −0.92, p < 0.001).
Figure 2 (A): Number of nigral Iba+ microglia at day 2 and day7.WT = WT mice, TLR def = TLR4-deficient mice. Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP-treated group with its saline control, #p < 0.05 comparing MPTP-treated groups of WT and TLR4-deficient mice). (B): MHC II+ cell number in SN after MPTP treatment at day 2. WT = WT mice, TLR def = TLR4-deficient mice. Values are expressed as mean ± SEM (*p < 0.05 comparing MPTP-treated group with its saline control, #p < 0.05 comparing MPTP-treated groups of WT and TLR4-deficient mice). (C): Representative photographs of the SN (Iba-1 staining) of each treatment group at day 2 are shown. TLR4 def = TLR4-deficient mice, WT = wild-type mice. Control = saline treated mice, MPTP = MPTP treated mice. Scale bars = 200 μm. (D): Correlation analysis of TH+- and Iba+-positive cells counts at day 7 in SNpc (r = −0.92, p < 0.001).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 1

  1. Fahn S., Parkinsonism P. S., & Rowland L. P. ed. Meritt's neurology 10th ed. New York: Lippincott, 2000, 679–693 (2000).

Cited by

See all 164

Metadata

Authors
Noelker, C., Morel, L., Lescot, T., Osterloh, A., Alvarez-Fischer, D., Breloer, M., Henze, C., Depboylu, C., Skrzydelski, D., Michel, P. P., Dodel, R. C., Lu, L., Hirsch, E. C., Hunot, S., & Hartmann, A.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Bernhard Nocht Institute for Tropical Medicine (DE)
  • Philipps University of Marburg (DE)
Corresponding author
  • Hunot, Stéphane
  • Hartmann, Andreas
Venue
Scientific Reports
Published
2013-03-06
Volume
3
Issue
1
Pages
1393-1393
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2093718309
Cited by
164
References
23
Citations by year
2026: 9 · 2025: 8 · 2024: 9 · 2023: 14 · 2022: 10 · 2021: 17 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 10 · 2016: 15 · 2015: 12 · 2014: 11 · 2013: 2
FWCI
8.46
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc-nd)
Funders
  • Michael J. Fox Foundation for Parkinson's Research
  • Deutsche Forschungsgemeinschaft
  • Institut National de la Santé et de la Recherche Médicale
  • Centre National de la Recherche Scientifique
  • Uniklinikum Giessen und Marburg
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
TLR4, Parkinson's disease, MPTP, dopaminergic neuron death, microglial activation, neuroinflammation, TLR4-deficient mice, substantia nigra, immune response
MeSH terms
Animals, Corpus Striatum, Dopamine, Homovanillic Acid, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Cell Death, Microglia, Mice, Knockout, Parkinsonian Disorders, Toll-Like Receptor 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.